149 related articles for article (PubMed ID: 2460487)
1. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
[TBL] [Abstract][Full Text] [Related]
2. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
[TBL] [Abstract][Full Text] [Related]
3. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
Krieg M; Nass R; Tunn S
J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
[TBL] [Abstract][Full Text] [Related]
4. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
Weisser H; Krieg M
Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
[TBL] [Abstract][Full Text] [Related]
6. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
[TBL] [Abstract][Full Text] [Related]
7. Potential activities of androgen metabolizing enzymes in human prostate.
Krieg M; Weisser H; Tunn S
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
Krieg M; Schlenker A; Voigt KD
Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
[TBL] [Abstract][Full Text] [Related]
10. [Activity of 5 alpha-reductase in human hyperplastic prostates].
Lin Y
Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
[TBL] [Abstract][Full Text] [Related]
11. 17 beta-hydroxysteroid oxidoreductase in epithelium and stroma of human prostate.
Tunn S; Schulze H; Krieg M
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):91-101. PubMed ID: 7687861
[TBL] [Abstract][Full Text] [Related]
12. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Lombardo ME; Hakky SI; Hall MK; Hudson PB
J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
[TBL] [Abstract][Full Text] [Related]
14. 5 alpha-androstane-3 beta,17 beta-diol hydroxylating enzymes in stroma and epithelium of human benign prostatic hyperplasia (BPH).
Tunn S; Claus S; Schulze H; Braun BE; Krieg M
J Steroid Biochem; 1987 Sep; 28(3):257-65. PubMed ID: 2443760
[TBL] [Abstract][Full Text] [Related]
15. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
Bartsch W; Krieg M; Becker H; Mohrmann J; Voigt KD
Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
Weisser H; Krieg M
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nuclear 5 alpha-reductase activities in the stromal and epithelial fractions of human prostatic tissue.
Hudson RW
J Steroid Biochem; 1987 Mar; 26(3):349-53. PubMed ID: 2438480
[TBL] [Abstract][Full Text] [Related]
18. [Benign prostatic hyperplasia--the outcome of age-induced alteration of androgen-estrogen balance?].
Weisser H; Krieg M
Urologe A; 1997 Jan; 36(1):3-9. PubMed ID: 9123678
[TBL] [Abstract][Full Text] [Related]
19. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
20. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
